Clinical Investigation on Safety, Performance and Effectiveness of Sono-instruments

Carpal Tunnel Syndrome Clinical Trial

— SONO-01  

Official title:

Prospective, Monocenter, Non-randomized Clinical Investigation Evaluating the Safety, Clinical Performance and Effectiveness of Sono-instruments for the Percutaneous Ultrasound-guided Treatment of Carpal Tunnel Syndrome and Trigger Finger

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05435950
• Other study ID #: SONO-01
• Status: Completed
• Phase: N/A
• Start date: September 2, 2022
• Est. completion date: March 10, 2023

Study information

• Verified date: May 2023
• Source: Spirecut
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Carpal Tunnel (CT) syndrome is a collection of characteristic symptoms and signs that occurs following compression of the median nerve within the CT. In Trigger Finger / trigger thumb (TF), one of the most common causes of hand pain and disability, the flexor tendon causes painful popping or snapping as the patient flexes and extends the digit. In case of failure of non-operative treatments, patients with CT syndrome or TF are operated. Clearly any improvement in surgical device design would be of great advantage to the patient and the surgeon. Spirecut's single use, pre-CE Sono-Instruments (SI) allow the percutaneous treatment of Carpal Tunnel (CT)syndrome and Trigger Finger/thumb (TF) under sonography (instead of open or endoscopic approach). Two models will be assessed in this clinical investigation:

1. The Carpal Tunnel Sono-Instrument® (CT-SI), for CT syndrome release, by progressively cutting the transverse carpal ligament.

2. The Trigger Finger Sono-Instrument® (TF-SI), for TF release by progressively cutting the A1 annual pulley.

Using those SI, surgical procedures can be performed without endangering adjacent structures (e.g. median nerve and branches, ulnar pedicle, superficial carpal arch, digital pedicles, flexor tendons).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: March 10, 2023
• Est. primary completion date: January 27, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Participants with Carpal tunnel syndrome:

Inclusion Criteria:

• Adults = 18 years of age;

• Primary CT confirmed by typical symptoms, signs and altered nerve conduction studies;

• Pain and/or numbness in the hand which worsen at night (or are present only at night);

• Participant and investigator signed and dated the Informed Consent Form (ICF) prior to the index-procedure.

Participants with Trigger Finger/thumb:

Inclusion Criteria:

• Adults = 18 years of age;

• Typical signs and symptoms of TF/thumb caused by friction or blockade of flexor tendon(s) in digital sheath, without flexion contracture over 30° of the proximal interphalangeal (or interphalangeal for the thumb) joint, confirmed by altered flexor tendon(s) gliding and/or increased thickness of A1 digital pulley under sonography (sonography can be done just before the operation, that is after signature of the ICF);

• Participant and investigator signed and dated the ICF prior to the index-procedure.

Exclusion criteria:

Participants with one or more of the following conditions are excluded from the study:

• Dwarfism or participants with small size hand/CT/TF-thumb;

• Past or active infection;

• Known allergic reaction to metals;

• Coagulation problems, with significant risk of per/postoperative bleeding;

• In case of TF: long evolution, with ankylosis of the proximal interphalangeal joint;

• In case of CT: severe median nerve dysfunction;

• Previous facture or dislocation in the operated area or any affection causing malalignment or distortion of the local skeleton due to trauma, arthritis or other causes;

• Other known clinical risks outweighing the expected clinical benefits or increasing the risk of a postoperative lesion (e.g. tissue adhesions, anatomical abnormalities, neuro-vascular structures in the zone of the intended release, local tumors);

• Insufficient sonographic identification of the operated tissue;

• Previous attempt to treat the condition;

• Currently receiving treatment for CT or TF;

• Contra-indication to local anesthesia (general, regional or local);

• Participant unable (vulnerable participant)/unwilling to provide informed consent;

• Participant is enrolled in another study.

Related Conditions & MeSH terms

• Carpal Tunnel Syndrome
• Syndrome
• Trigger Finger
• Trigger Finger Disorder
• Trigger Thumb

Intervention

Device:
• Sono-Intruments
Spirecut's single use, pre-CE Sono-Instruments (SI) allow the percutaneous treatment of Carpal Tunnel (CT) syndrome and Trigger Finger/thumb (TF) under sonography (instead of open or endoscopic approach). Two models will be assessed: The Carpal Tunnel Sono-Instrument® (CT-SI), for CT syndrome release, by progressively cutting the transverse carpal ligament. The Trigger Finger Sono-Instrument® (TF-SI), for TF release by progressively cutting the A1 annual pulley.

Locations

Country	Name	City	State
Belgium	Erasme University Hospital	Brussels

Sponsors (2)

Lead Sponsor	Collaborator
Spirecut	Archer Research

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Safety of percutaneous surgery performed with Sono-Instuments	Number of peri- and post-operative (serious) adverse events, including operative and post-operative complications (e.g. infection), symptomatic recurrences and re-interventions.	During the index procedure
Primary	Safety of percutaneous surgery performed with Sono-Instuments	Number of peri- and post-operative (serious) adverse events, including operative and post-operative complications (e.g. infection), symptomatic recurrences and re-interventions.	Within 1 week after the procedure
Primary	Safety of percutaneous surgery performed with Sono-Instuments	Number of peri- and post-operative (serious) adverse events, including operative and post-operative complications (e.g. infection), symptomatic recurrences and re-interventions.	6 weeks after the procedure
Secondary	Performance of Sono-Instruments during percutaneous surgery	Ease of positioning of Sono-Instruments during percutaneous surgery. A score ranging from 0 (very unsatisfied) to 4 (very satisfied) will be documented by surgeons experienced in performing percutaneous surgery.	During the index procedure
Secondary	Performance of Sono-Instruments during percutaneous surgery	Maneuverability of Sono-Instruments during percutaneous surgery. A score ranging from 0 (very unsatisfied) to 4 (very satisfied) will be documented by surgeons experienced in performing percutaneous surgery.	During the index procedure
Secondary	Performance of Sono-Instruments during percutaneous surgery	Visibility (location and orientation) of the Sono-Instruments under sonography. A score ranging from 0 (very unsatisfied) to 4 (very satisfied) will be documented by surgeons experienced in performing percutaneous surgery.	During the index procedure
Secondary	Performance of Sono-Instruments during percutaneous surgery	Technical success of the surgical procedure, defined as percutaneous surgery as intended without technical difficulties and without conversion to another surgical intervention.	During the index procedure
Secondary	Pre-operative pain	Pain is assessed using the Numeric pain Rating Scale (NRS) in rest and activity (e.g. use for light daily activities like eating with the operated hand, putting the clothes on, washing the hands etc.). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").	During screening
Secondary	Post-operative pain of percutaneous surgery performed with Sono-Instruments	Pain is assessed using the Numeric pain Rating Scale (NRS) in rest and activity (e.g. use for light daily activities like eating with the operated hand, putting the clothes on, washing the hands etc.). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").	Within 1 week after the procedure
Secondary	Post-operative pain of percutaneous surgery performed with Sono-Instruments	Pain is assessed using the Numeric pain Rating Scale (NRS) in rest and activity (e.g. use for light daily activities like eating with the operated hand, putting the clothes on, washing the hands etc.). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").	6 weeks after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Document use of anti-inflammatory/pain medications.	During screening
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Document what the participant cannot do with his/her affected hand.	During screening
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, including 11 items with 5 response options each (1 = no problem with activity, 5 = activity is not possible).	During screening
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Boston Carpal Tunnel Questionnaire Symptom Severity (BCTQ-SS) in patients with carpal tunnel syndrome, including 11 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).	During screening
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Boston Carpal Tunnel Questionnaire Functional Scale (BCTQ-FS) in patients with carpal tunnel syndrome, including 8 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).	During screening
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Noting of numbness/pain at night in patients with carpal tunnel syndrome.	During screening
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Quinnell grading system in patients with trigger finger/thumb, including 2 items with 5 response options each (0 = normal movement of the digit, 4 = fixed deformity).	During screening
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Document use of anti-inflammatory/pain medication.	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Document use of anti-inflammatory/pain medication.	6 weeks after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Document what the participant cannot do with his/her affected hand.	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Document what the participant cannot do with his/her affected hand.	6 weeks after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, including 11 items with 5 response options each (1 = no problem with activity, 5 = activity is not possible).	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, including 11 items with 5 response options each (1 = no problem with activity, 5 = activity is not possible).	6 weeks after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Post-operative time to return to activities of daily living as prescribed by the doctor and effectively done by participant.	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Post-operative time to return to work as prescribed by the doctor and effective return to work for participants that are employed.	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Number of days between surgery and washing of the operated hand for the first time.	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Boston Carpal Tunnel Questionnaire Symptom Severity (BCTQ-SS) in patients with carpal tunnel syndrome, including 11 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Boston Carpal Tunnel Questionnaire Symptom Severity (BCTQ-SS) in patients with carpal tunnel syndrome, including 11 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).	6 weeks after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Boston Carpal Tunnel Questionnaire Functional Scale (BCTQ-FS) in patients with carpal tunnel syndrome, including 8 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Boston Carpal Tunnel Questionnaire Functional Scale (BCTQ-FS) in patients with carpal tunnel syndrome, including 8 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).	6 weeks after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Noting of numbness/pain at night in patients with Carpal Tunnel Syndrome.	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Noting of numbness/pain at night in patients with Carpal Tunnel Syndrome.	6 weeks after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Noting of pillar pain in patients with Carpal Tunnel Syndrome.	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Noting of pillar pain in patients with Carpal Tunnel Syndrome.	6 weeks after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Quinnell grading system in patients with trigger finger/thumb, including 2 items with 5 response options each (0 = normal movement of the digit, 4 = fixed deformity).	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Quinnell grading system in patients with trigger finger/thumb, including 2 items with 5 response options each (0 = normal movement of the digit, 4 = fixed deformity).	6 weeks after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Modified Patel and Bassini's grading system in patients with trigger finger/thumb, including 2 items with 4 response options each (1 = no improvement, 4 = full improvement).	Within 1 week after the procedure
Secondary	Clinical effectiveness of percutaneous surgery performed with Sono-Instruments	Modified Patel and Bassini's grading system in patients with trigger finger/thumb, including 2 items with 4 response options each (1 = no improvement, 4 = full improvement).	6 weeks after the procedure